Solving a puzzle

February 03, 2021

Tuberous sclerosis complex (TSC) afflicts as many as two million people around the world, affecting multiple organs, including lungs, brain, skin and kidneys. In about 80 percent of cases, it causes cysts and benign tumors to form in the kidney, eventually resulting in kidney failure.

It's known that the disease is triggered by genetic mutations, but how these mutations lead to the formation of kidney cysts has been poorly understood - until now.

Nephrologist Manoocher Soleimani, MD, a professor in The University of New Mexico Department of Internal Medicine, led a team that solved the puzzle and pointed the way toward potential treatments for this devastating condition.

In a paper published this week in the Proceedings of the National Academy of Sciences, Soleimani and his colleagues report that unexpected changes in the composition and function of cells lining the collecting ducts that funnel fluid from kidney into the urinary tract are to blame.

"Kidneys form cysts in this disease, which continue to expand and get bigger and bigger and bigger," Soleimani says. "There is no good treatment."

A class of medications called mTOR inhibitors can shrink the cysts in about half of the patients treated, but the other half don't respond, he says. And if the treatments are discontinued, the cysts grow back, ultimately leading to kidney failure.

In exploring how mutations cause cysts to form and grow, Soleimani and colleagues at UNM, the Albuquerque Veterans Affairs Medical Center, Harvard University, the University of Cincinnati and the University of Tennessee focused on the two types of cells in the collecting ducts - principal cells and intercalated cells. In a healthy kidney, principal cells are responsible for fluid transport, while intercalated cells secrete acid.

Using a knockout strain of specially bred mice, Soleimani's team simulated the effects of the TSC gene mutation in the principal cells and examined the cysts that formed in the kidneys.

"We thought the cells lining the cysts would be principal," Soleimani says. "We were completely wrong! Ninety-five percent of the cells lining the cysts were comprised of intercalated cells. This was completely unexpected, and has never been reported."

Stranger still, as the cysts budded and grew into fluid-filled sacs, the genetically normal intercalated cells began behaving differently, excreting fluid, as well as acid. "They were genetically normal but functioning in an abnormal way," Soleimani says.

Looking more deeply into the problem, the team engineered double knock-out mice that lacked both the original cyst-driving mutation and a key gene driving the secretion of acid in the collecting ducts. "We found, to our pleasant surprise, that cyst size and numbers decreased by 85 to 90 percent in one double knock-out mouse model and were completely prevented in another double knock-out model," he says.

Zeroing in on the acid-secreting gene "opens new avenues" for potential treatments, Soleimani says, because existing FDA-approved medications are known to suppress its function.

Soleimani, who also provides clinical care at the VA Medical Center as well as UNM Hospital, recently received grant funding from the U.S. Department of Veterans Affairs for further research on kidney cysts in TSC.

"We are proposing to try to manipulate the activity of these molecules using medication," he says. "First we are going to do it in mice, but we are linking up with physicians that are taking care of TSC patients, and then we are going to move to try these medications in human beings."
-end-


University of New Mexico Health Sciences Center

Related Internal Medicine Articles from Brightsurf:

COVID-19 news from Annals of Internal Medicine
In this Ideas and Opinions piece from the University of California, San Francisco and San Francisco Veterans Affairs Medical Center, the authors discuss the findings of early studies that addressed the use of chest computed tomography for the detection of COVID-19.

New COVID-19 content from Annals of Internal Medicine
Below please find links to new coronavirus-related content published today in Annals of Internal Medicine.

Changes in internal medicine subspecialty choices of women, men
This study used enrollment data to examine changes in the internal medicine subspecialty choices of women and men from 1991 to 2016.

Do internal medicine residents feel bullied during training?
This research letter uses survey data to report on perceived bullying by internal medicine residents during training.

Annals publishes annual updates in internal medicine
Annals of Internal Medicine, the flagship journal of the American College of Physicians (ACP), has published summaries of the most important medical studies published in 2016 in the fields of general internal medicine, cardiology, hematology, endocrinology, gastroenterology and hepatology, rheumatology, and perioperative, pulmonary, and geriatric medicine.

News from Annals of Internal Medicine April 7, 2015
In the next issue of Annals of Internal Medicine are: Weight Watchers and Jenny Craig come out on top among commercial weight loss programs; Physical therapy as effective as surgery for lumber spinal stenosis; and Leading internists call for more thoughtful use of CPR.

News from Annals of Internal Medicine March 31, 2015
Articles include: USPSTF reviews evidence to update recommendations on iron supplementation and deficiency screening in pregnant women; New hep C treatments are cost-effective for some patients, yet may exceed insurers' willingness to pay.

News from Annals of Internal Medicine March 24, 2015
The US Preventive Services Task Force concludes that the current evidence is insufficient to recommend for or against screening for thyroid dysfunction in nonpregnant, asymptomatic adults.

News from Annals of Internal Medicine Feb. 10, 2015
Using Lung Imaging Reporting and Data System (Lung-RADS) criteria developed by the American College of Radiology to interpret low-dose CT lung screening results may reduce false positives compared to the National Lung Screening Trial, but the trade-off is reduced sensitivity, according to an article published in Annals of Internal Medicine.

News from Dec. 23, 2014, Annals of Internal Medicine
The Dec. 23, 2014, issue of Annals of Internal Medicine includes 'Blood pressure drugs likely to prevent stroke and death in patients with mild hypertension' and 'Task force reviews evidence to update blood pressure screening recommendations.'

Read More: Internal Medicine News and Internal Medicine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.